Skip to main content
  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
Logo image Logo image
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline (Opens in a new tab/window)
      • PBM Guidelines (Opens in a new tab/window)
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines (Opens in a new tab/window)
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Search

  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline
      • PBM Guidelines
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Patient blood management guideline for adults with critical bleeding

  • Home
  • Patient blood management guideline for adults with critical bleeding

This guideline updates the Patient Blood Management Guidelines: Module 1 Critical bleeding/massive transfusion (2011).

It aims to provide updated clinical guidance for health professionals providing immediate in-hospital care for adults with critical bleeding, including the use of a major haemorrhage protocol (MHP) to guide the use of blood components, blood products and blood conservation strategies.

The clinical guidance is based on scientific evidence and consensus among clinical experts. The NBA gratefully acknowledges the dedication and expertise provided by the multidisciplinary Clinical/Consumer Reference Group (CRG).

The guideline was published on 10 August 2023 in electronic format and on MAGICapp, a web-based platform for guidelines.

In September 2025 a minor update was made to Good Practice Statement 5 after consensus was received from the CRG. This updated version of the guideline was published on 4 September 2025 in electronic format and on MAGICapp.  

Guideline

This guideline is maintained on MAGICapp(Opens in a new tab/window). The electronic version on MAGICapp and the PDF version below are the approved version and most current. Any downloaded or printed version is current only for the day it was printed or saved.

  • Patient blood management guideline for adults with critical bleeding
    843.77 KB

Any updates to the guideline will be acknowledged here. To keep up to date with the latest changes to this guideline, click subscribe on the MAGICapp website.

Summary of clinical guidance

Our quick reference guide comprises a:

  • summary of the recommendations developed by the CRG, based on a systematic review of evidence
  • summary of the good practice statements that were developed by the CRG through an expert consensus process
  • MHP template, which is designed to be adapted to meet local needs and resources.

To make a handy booklet, print the A5 file double-sided on the ‘short edge’ and fold the 2 pages.

  • Quick Reference Guide - A5 format
    812.97 KB
  • Quick Reference Guide - A4 format
    984.46 KB

Major haemorrhage protocol (MHP) template

An editable template to be adapted to local institutional requirements and resources.

  • Major Haemorrhage Protocol.pptx
    169.69 KB

Technical report on the methodology and findings of the evidence review process

  • Volume 1 - Description of the methodology and results of the evidence review process (pdf)
    38.78 MB
  • Volume 2 - Literature searches and critical appraisal of the studies (pdf)
    33.59 MB
  • Volume 3 - Data extraction forms (pdf)
    5.38 MB

College and society endorsements

We greatly appreciate and acknowledge the input received from the clinical community in producing the guideline. We are pleased to acknowledge that the following organisation has formally endorsed the guideline:

  • Australian & New Zealand Society of Blood Transfusion

PBM updates

Keep up to date with updates on patient blood management and our guidelines by subscribing to the PBM mailing list through BloodPortal.(Opens in a new tab/window)

Get in touch

We welcome feedback on this guideline to inform future reviews or the development of materials to support implementation.

Email: guidelines@blood.gov.au

Last updated: 05 Sep 2025

The National Blood Authority acknowledges the Traditional Owners and Custodians of Country throughout Australia, and their continuing connection to land, water and community. We pay our respects to the people, the cultures and the elders past, present and emerging.

National Blood Authority

  • About the NBA
  • Work with us
  • Contact Us
  • Data and reporting
  • Freedom of information
  • Public interest disclosure
  • Resources
  • Accessibility
  • Privacy
  • Copyright
  • Disclaimer
  • BloodPortal Terms and Conditions of Use

Information

  • Blood Products
  • Managing blood supply
  • Supply systems
  • Clinical guidance
  • Patient information
  • Data and research
  • Website feedback